Journal
CIRCULATION RESEARCH
Volume 106, Issue 4, Pages 705-U148Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.109.210047
Keywords
troponin; thin filament; myocardial stunning; cardiomyopathy
Funding
- NIH [R01 HL36153, R01 AR34711, R01 HL63038, P01 AR41637]
- American Heart Association
- Boston Biomedical Research Institute
Ask authors/readers for more resources
Rationale: Ca2+ control of troponin-tropomyosin position on actin regulates cardiac muscle contraction. The inhibitory subunit of troponin, cardiac troponin (cTn) I is primarily responsible for maintaining a tropomyosin conformation that prevents crossbridge cycling. Despite extensive characterization of cTnI, the precise role of its C-terminal domain (residues 193 to 210) is unclear. Mutations within this region are associated with restrictive cardiomyopathy, and C-terminal deletion of cTnI, in some species, has been associated with myocardial stunning. Objective: We sought to investigate the effect of a cTnI deletion-removal of 17 amino acids from the C terminus-on the structure of troponin-regulated tropomyosin bound to actin. Methods and Results: A truncated form of human cTnI (cTnI(1-192)) was expressed and reconstituted with troponin C and troponin T to form a mutant troponin. Using electron microscopy and 3D image reconstruction, we show that the mutant troponin perturbs the positional equilibrium dynamics of tropomyosin in the presence of Ca2+. Specifically, it biases tropomyosin position toward an enhanced C-state that exposes more of the myosin-binding site on actin than found with wild-type troponin. Conclusions: In addition to its well-established role of promoting the so-called blocked-state or B-state, cTnI participates in proper stabilization of tropomyosin in the Ca2+-activated state or C-state. The last 17 amino acids perform this stabilizing role. The data are consistent with a fly-casting model in which the mobile C terminus of cTnI ensures proper conformational switching of troponin-tropomyosin. Loss of actin-sensing function within this domain, by pathological proteolysis or cardiomyopathic mutation, may be sufficient to perturb tropomyosin conformation. (Circ Res. 2010; 106: 705-711.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available